Clinical validation and utility of Percepta GSC for the evaluation of lung cancer

Clinical validation and utility of Percepta GSC for the evaluation of lung cancer

Show other versions (1)

The Percepta Genomic Sequencing Classifier (GSC) was developed to up-classify as well as down-classify the risk of malignancy for lung lesions when bronchoscopy is non-diagnostic. We evaluated the performance of Percepta GSC in risk re-classification of indeterminate lung lesions. This multicenter s...

Full description

Bibliographic Details
Main Authors: Peter Mazzone, Travis Dotson, Momen M. Wahidi, Michael Bernstein, Hans J. Lee, David Feller Kopman, Lonny Yarmus, Duncan Whitney, Christopher Stevenson, Jianghan Qu, Marla Johnson, P. Sean Walsh, Jing Huang, Lori R. Lofaro, Sangeeta M. Bhorade, Giulia C. Kennedy, Avrum Spira, M. Patricia Rivera, The AEGIS Study Team, The Percepta Registry Investigators
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278743/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278743/?tool=EBI

Similar Items